Magellan Health (MGLN) Tops Q1 EPS Views; Updates FY15 Outlook

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.94, $0.55 better than the analyst estimate of $0.39. Revenue for the quarter came in at $981 million versus the consensus estimate of $1.02 billion.

Magellan Health sees FY2015 EPS of $3.41-$3.85, versus the consensus of $2.40. Magellan Health sees FY2015 revenue of $4.45-4.69 billion, versus the consensus of $4.47 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• VNET Group (VNET) Misses Q2 EPS by 164c